Prevalence, pattern and clinical implications of transfusion transmissible viral infections among paediatric haemophiliacs in northern Nigeria
References
- Ibrahim UA, Ahmed SG. Pathophysiology of bleeding diathesis in haemophilia A: A sequential and critical appraisal of non-FVIII related haemostatic dysfunctions and their therapeutic implications. Egypt J Med Hum Genet 2018; 19: 285–95. doi: 10.1016/j.ejmhg.2018.01.003.
- Brinkmann T, Kähnert H, Prohaska W, et al. Synthesis of tissue factor pathway inhibitor in human synovial cells and chondrocytes makes joints the predilected site of bleeding in haemophiliacs. Eur J Clin Chem Clin Biochem 1994; 32: 313–317.
- Nieuwenhuizen L, Schutgens RE, van Asbeck BS, et al. Identification and expression of iron regulators in human synovium: evidence for up-regulation in haemophilic arthropathy compared to rheumatoid arthritis, osteoarthritis, and healthy controls. Haemophilia 2013;19: e218–e227. doi:10.1111/hae.12208.
- Qasim Z, Naseem L, Asif N, Hassan K. Haemophilia: pattern of clinical presentation and disease severity. Int J Pathol 2013; 11: 58–63.
- Ibrahim UA, Ahmed SG, Kagu MB, Abjah UA. Frequency and clinical significance of schistosomiasis in haemophilia. J Haem Pract 2016; 3: 39–43. doi: 10.17225/jhp00074.
- Ibrahim UA, Ahmed SG, Kagu MB, Abjah UA. Impact of intestinal helminths on the risks of gastrointestinal haemorrhage and iron deficiency among haemophilia patients in northern Nigeria. J Haem Pract 2017; 4: 1–7. doi:10.17225/ jhp00097.
- Ahmed SG, Kagu MB, Ibrahim UA, Bukar AA. Frequency of iron deficiency among patients with haemophilia-A in northern Nigeria: correlation with the disease severity and clinical Implications. Egypt J Haematol 2015; 40: 85–9. doi:10.4103/1110-1067.161294.
- Ghosh K, Ghosh K. Management of haemophilia in developing countries: challenges and options. Indian J Haematol Blood Transfus 2016; 32:347–55. doi:10.1007/s12288-015-0562-x.
- Ahmed SG, Kagu MB, Ibrahim UA. Pattern of blood products transfusions and reactions among multi-transfused haemophiliacs in Nigeria: implications on haemophilia care in low resource tropical settings. Sudan Med J 2018, 54: 29–38. doi: 10.12816/0046389.
- Osaro E, Charles AT. The challenges of meeting the blood transfusion requirements in Sub-Saharan Africa: the need for the development of alternatives to allogenic blood. J Blood Med 2011; 2:7. doi: 10.2147/JBM.S17194.
- Bloch EM, Vermeulen M, Murphy E. Blood transfusion safety in Africa: a literature review of infectious disease and organizational challenges. Transfus Med Rev 2012; 26: 164–80. doi:10.1016/j.tmrv.2011.07.006.
- Nwankwo E, Momodu I, Umar I, et al. Seroprevalence of major blood-borne infections among blood donors in Kano, Nigeria. Turk J Med 2012; 42: 337–41. doi:10.3906/sag-1009-1176.
- Okoroiwu HU, Okafor IM, Asemota EA, Okpokam DC. Seroprevalence of transfusion-transmissible infections (HBV, HCV, syphilis and HIV) among prospective blood donors in a tertiary health care facility in Calabar, Nigeria; an eleven years evaluation. BMC Public Health 2018; 18: 645. doi: 10.1186/ s12889-018-5555-x.
- Abimiku AG, Zwandor A, Gomwalk N, et al. HIV-1, not HIV-2, is prevalent in Nigeria: need for consideration in vaccine plans. Vaccine Res 1994; 3: 101–4.
- Aneke JC, Okocha CE. Blood transfusion safety; current status and challenges in Nigeria. Asian J Transfus Sci 2017; 11: 1–5. doi: 10.4103/0973-6247.200781.
- Osaro E, Mohammed N, Zama I, et al. Prevalence of p24 antigen among a cohort of HIV antibody negative blood donors in Sokoto, North Western Nigeria-the question of safety of blood transfusion in Nigeria. Pan Afr Med J 2014; 18. doi: 10.11604/pamj.2014.18.174.3449.
- Lieshout-Krikke RW, Zaaijer HL, van de Laar TJW. Predonation screening of candidate donors and prevention of window period donations. Transfusion 2015; 55: 373–8.
- Stonebraker JS, Bolton-Maggs PH, Soucie JM, et al. A study of variations in the reported haemophilia A prevalence around the world. Haemophilia 2010;16:20–32. doi: 10.1111/j.1365-2516.2009.02127.x.
- Laffan M, Manning R. Investigation of haemostasis. In: Lewis SM, Bain BJ, Bates I, eds. Practical Haematology 10th edn. London, Churchill Livingstone; 2006: 379–440.
- Olayinka AT, Oyemakinde A, Balogun MS, et al. Seroprevalence of hepatitis B infection in Nigeria: a national survey. Am J Trop Med Hyg 2016; 95: 902–7. doi: 10.4269/ajtmh.15-0874.
- Karoney MJ, Siika AM. Hepatitis C virus (HCV) infection in Africa: a review. Pan Afr Med J 2013; 14: 44. doi: 10.11604/ pamj.2013.14.44.2199.
- Awofala AA, Ogundele OE. HIV epidemiology in Nigeria. Saudi J Biol Sci 2018; 25: 697–703. doi: 10.1016/j.sjbs.2016.03.006.
- Keechilot CS, Shenoy V, Kumar A, et al. Detection of occult hepatitis B and window period infection among blood donors by individual donation nucleic acid testing in a tertiary care center in South India. Pathog Global Health 2016; 110: 287291. doi: 10.1080/20477724.2016.1248171.
- Mehra B, Bhattar S, Bhalla P, Rawat D. Rapid tests versus ELISA for screening of HIV infection: our experience from a voluntary counselling and testing facility of a tertiary care centre in North India. ISRN AIDS 2014; 2014: 296840. doi: 10.1155/2014/296840.
- Orkuma JA, Egesie JO, Banwat EB, et al. HIV screening in blood donors: rapid diagnostic test versus enhanced ELISA. Niger J Med 2014; 23: 192–200.
- Yang JF, Lin YY, Hsieh MH, et al. Performance characteristics of a combined hepatitis C virus core antigen and anti–hepatitis C virus antibody test in different patient groups. Kaohsiung J Med Sci 2011; 27: 258–63. doi: 10.1016/j.kjms.2010.11.007.
- Chigurupati P, Murthy KS. Automated nucleic acid amplification testing in blood banks: an additional layer of blood safety. Asian J Transfus Sci 2015; 9: 9–11. doi: 10.4103/0973-6247.150938.
- Devine DV, Schubert P. Pathogen inactivation technologies: the advent of pathogen-reduced blood components to reduce blood safety risk. Hematol Oncol Clin 2016; 30: 609–17. doi: 10.1016/j.hoc.2016.01.005.
- Chaabna K, Kouyoumjian SP, Abu-Raddad LJ. Hepatitis C virus epidemiology in Djibouti, Somalia, Sudan, and Yemen: systematic review and meta-analysis. PLoS ONE 2016; 11(2): e0149966-e0149966. doi: 10.1371/journal.pone.0149966.
- Abdelwahab MS, El-Raziky MS, Kaddah NA, Abou-Elew HH. Prevalence of hepatitis C virus infection and human immunodeficiency virus in a cohort of Egyptian hemophiliac children. Ann Saudi Med 2012; 32: 200–2. doi: 10.5144/02564947.2012.200.
- Borhany M, Shamsi T, Boota S, et al. Transfusion transmitted infections in patients with hemophilia of Karachi, Pakistan. Clin Appl Thromb Hemost 2011; 17: 651–5. doi: 10.1177/1076029611398122.
- Makris M, Preston FE. Chronic hepatitis in haemophilia. Blood Rev 1993; 7: 243–50. doi: 10.1016/0268-960X(93)90011-R.
- Heinz S, Braspenning J. Measurement of blood coagulation factor synthesis in cultures of human hepatocytes. Methods Mol Biol 2015; 1250: 309–16. doi: 10.1007/978-1-4939-20747_23.
- Lim SG, Lee CA, Kernoff PB. The treatment of HIV associated thrombocytopenia in haemophiliacs. Int J Lab Hematol 1990; 12: 237–45. doi: 10.1111/j.1365-2257.1990.tb00033.x.
- Lee CA. Blood borne infections and haemophilia: the worst of times. J Haem Pract 2015; 2: 5–7. doi: 10.17225/jhp00049.
- Loomans JI, Kruip MJ, Carcao M, et al. Desmopressin in moderate hemophilia-A patients: a treatment worth considering. Haematologica 2018; 103: 550–7. doi: 10.3324/ haematol.2017.180059.
- Hart D, Badle S. Anti-fibrinolytic agents in bleeding disorders – a clinical perspective. J Haem Pract 2016; 3: 1–4. doi: 10.17225/jhp00089.
DOI: https://doi.org/10.17225/jhp00117 | Journal eISSN: 2055-3390
Language: English
Page range: 103 - 110
Published on: Jan 18, 2019
Published by: Haemnet Ltd
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
Related subjects:
© 2019 Sagir G. Ahmed, Umma A. Ibrahim, Modu B. Kagu, published by Haemnet Ltd
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.